Cont.
It's a long text - for those who might be interested in it;
http://www.uwyo.edu/psychology/_file...commentary.pdf
This excerpt says it all;
Several recent NIMH clinical trials have demonstrated that psychiatric medications for mood disorders also produce poor long-term outcomes. Perhaps the most striking example is the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, the largest antidepressant effectiveness study ever conducted. This investigation revealed that the vast majority of depressed patients do not experience long-term remission with newer-generation antidepressants, even when given the opportunity to switch from one medication to another up to three times in the event of non-response (Rush et al., 2006). Under “best-practice” conditions designed to maximize the likelihood of achieving and maintaining remission, only 3% of patients who initially benefited from antidepressant medication maintained their improvement and remained in the study at 12-month follow-up (Pigott, 2011). In the Systematic Treatment Enhancement Program for Bipolar Disorder study (STEP-BD; Schneck et al., 2008), only 23% of patients with bipolar disorder who received treatment in accordance with best-practice psychiatric guidelines (APA, 2002) remained well and continuously enrolled in the study during the one-year follow-up period. The remainder either dropped out (32%) or suffered a recurrence of a mood episode (45%).
